Side Effects of Flunisolide Inhalers
A few common side effects of flunisolide inhalers include nasal congestion, a sore throat, headaches, and vomiting. Some less common side effects (reported in less than 3 percent of people taking the drug) include bloody nose, gas, and weight gain. There are also a number of flunisolide inhaler side effects that are more serious and should be reported to a healthcare provider immediately, such as a rapid heart rate, high blood pressure, and anxiety.
As with any medicine, there are possible side effects with the flunisolide inhaler (Aerobid®); however, not everyone who uses the inhaler will experience side effects. In fact, most people tolerate flunisolide inhalers well. When side effects do occur, in most cases they are minor and either require no treatment or can easily be treated by you or your healthcare provider.
(This article covers many, but not all, of the possible side effects with flunisolide inhalers. Your healthcare provider can discuss a more complete list of flunisolide inhaler side effects with you.)
Flunisolide inhalers will not be made, dispensed, or sold in the United States after June 30, 2011. Flunisolide inhalers contain chlorofluorocarbons (CFCs), chemicals that deplete the ozone layer. The U.S. Food and Drug Administration (FDA) has set this final date for the medication in order to comply with the Montreal Protocol on Substances That Deplete the Ozone Layer. People using the flunisolide inhaler should ask their healthcare providers about alternatives to the medication, keeping in mind that it is possible that flunisolide inhalers may become unavailable in pharmacies earlier than the final date.